Most cited article - PubMed ID 30872754
UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study
The bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 has been previously identified as a more potent analog of dexrazoxane (ICRF-187), a drug used in clinical practice against anthracycline cardiotoxicity. However, the poor aqueous solubility of ICRF-193 has precluded its further in vivo development as a cardioprotective agent. To overcome this issue, water-soluble prodrugs of ICRF-193 were prepared, their abilities to release ICRF-193 were investigated using a novel UHPLC-MS/MS assay, and their cytoprotective effects against anthracycline cardiotoxicity were tested in vitro in neonatal ventricular cardiomyocytes (NVCMs). Based on the obtained results, the bis(2-aminoacetoxymethyl)-type prodrug GK-667 was selected for advanced investigations due to its straightforward synthesis, sufficient solubility, low cytotoxicity and favorable ICRF-193 release. Upon administration of GK-667 to NVCMs, the released ICRF-193 penetrated well into the cells, reached sufficient intracellular concentrations and provided effective cytoprotection against anthracycline toxicity. The pharmacokinetics of the prodrug, ICRF-193 and its rings-opened metabolite was estimated in vivo after administration of GK-667 to rabbits. The plasma concentrations of ICRF-193 reached were found to be adequate to achieve cardioprotective effects in vivo. Hence, GK-667 was demonstrated to be a pharmaceutically acceptable prodrug of ICRF-193 and a promising drug candidate for further evaluation as a potential cardioprotectant against chronic anthracycline toxicity.
- MeSH
- Anthracyclines adverse effects MeSH
- Dexrazoxane chemistry pharmacology MeSH
- Diketopiperazines chemistry pharmacology MeSH
- DNA Topoisomerases, Type II metabolism MeSH
- Topoisomerase II Inhibitors chemistry pharmacology MeSH
- Myocytes, Cardiac drug effects metabolism MeSH
- Cardiotonic Agents chemistry pharmacology MeSH
- Cardiotoxicity drug therapy metabolism MeSH
- Rabbits MeSH
- Piperazine chemistry pharmacology MeSH
- Prodrugs chemistry pharmacology MeSH
- Razoxane chemistry pharmacology MeSH
- Water chemistry MeSH
- Animals MeSH
- Check Tag
- Rabbits MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione MeSH Browser
- Anthracyclines MeSH
- Dexrazoxane MeSH
- Diketopiperazines MeSH
- DNA Topoisomerases, Type II MeSH
- Topoisomerase II Inhibitors MeSH
- Cardiotonic Agents MeSH
- Piperazine MeSH
- Prodrugs MeSH
- Razoxane MeSH
- Water MeSH